WallStSmart

Coherent Inc (COHR)vsItron Inc (ITRI)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Coherent Inc generates 207% more annual revenue ($7.12B vs $2.32B). ITRI leads profitability with a 12.0% profit margin vs 11.3%. ITRI appears more attractively valued with a PEG of 0.73. ITRI earns a higher WallStSmart Score of 67/100 (B-).

COHR

Buy

65

out of 100

Grade: C+

Growth: 9.3Profit: 5.5Value: 4.0Quality: 7.0
Piotroski: 5/9Altman Z: 1.90

ITRI

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 7.0Value: 6.0Quality: 7.5
Piotroski: 4/9Altman Z: 1.79
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

COHRSignificantly Overvalued (-34.3%)

Margin of Safety

-34.3%

Fair Value

$164.97

Current Price

$237.17

$72.20 premium

UndervaluedFair: $164.97Overvalued
ITRISignificantly Overvalued (-23.1%)

Margin of Safety

-23.1%

Fair Value

$81.10

Current Price

$92.59

$11.49 premium

UndervaluedFair: $81.10Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COHR3 strengths · Avg: 9.3/10
Revenue GrowthGrowth
33.7%10/10

Revenue surging 33.7% year-over-year

EPS GrowthGrowth
73.0%10/10

Earnings expanding 73.0% YoY

PEG RatioValuation
0.928/10

Growing faster than its price suggests

ITRI4 strengths · Avg: 8.5/10
Debt/EquityHealth
0.0910/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.738/10

Growing faster than its price suggests

P/E RatioValuation
15.0x8/10

Attractively priced relative to earnings

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Areas to Watch

COHR4 concerns · Avg: 2.8/10
Altman Z-ScoreHealth
1.904/10

Grey zone — moderate risk

Return on EquityProfitability
7.4%3/10

ROE of 7.4% — below average capital efficiency

P/E RatioValuation
56.5x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-493.40M2/10

Negative free cash flow — burning cash

ITRI2 concerns · Avg: 4.0/10
Revenue GrowthGrowth
3.0%4/10

3.0% revenue growth

Altman Z-ScoreHealth
1.794/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : COHR

The strongest argument for COHR centers on Revenue Growth, EPS Growth, PEG Ratio. Revenue growth of 33.7% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.

Bull Case : ITRI

The strongest argument for ITRI centers on Debt/Equity, PEG Ratio, P/E Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.

Bear Case : COHR

The primary concerns for COHR are Altman Z-Score, Return on Equity, P/E Ratio. A P/E of 56.5x leaves little room for execution misses.

Bear Case : ITRI

The primary concerns for ITRI are Revenue Growth, Altman Z-Score.

Key Dynamics to Monitor

COHR profiles as a growth stock while ITRI is a value play — different risk/reward profiles.

COHR carries more volatility with a beta of 2.11 — expect wider price swings.

COHR is growing revenue faster at 33.7% — sustainability is the question.

ITRI generates stronger free cash flow (81M), providing more financial flexibility.

Bottom Line

ITRI scores higher overall (67/100 vs 65/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coherent Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a variety of scientific, commercial, and industrial research applications. The company is headquartered in Santa Clara, California.

Itron Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Itron, Inc., a technology and services company, offers end-to-end solutions that help manage energy, water, and smart city operations globally. The company is headquartered in Liberty Lake, Washington.

Want to dig deeper into these stocks?